Introduction {#s1}
============

Although coronary angiography has remained the gold standard for the diagnosis of coronary artery disease (CAD), the assessment of functional lesion relevance cannot be based on purely morphologic criteria. Indeed, many factors other than lumen size which cannot be comprehensively evaluated by coronary angiography alone determine whether or not a lesion induces myocardial ischaemia.^[@EHR232C1]^ Nevertheless, in clinical practice, a luminal narrowing greater than 50% is widely used as a cut-off to define the presence of relevant CAD. For prognostically relevant target vessel revascularization comprehensive evaluation including proof of ischaemia is mandatory, because interventions on non-flow limiting stenoses confer no prognostic or symptomatic benefit to the patients, but are still associated with the risk of the intervention.^[@EHR232C2],[@EHR232C3]^ As a consequence, non-invasive functional assessment with single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has been suggested as gatekeeper for coronary angiography.^[@EHR232C4],[@EHR232C5]^ Up until recently, complimentary information on coronary artery anatomy and the degree and site of myocardial ischaemia has been integrated mentally by combining the information obtained from invasive coronary angiography and SPECT-MPI, respectively. Unfortunately, however, standard myocardial distribution territories correspond in only 50--60% to the real anatomic tree.^[@EHR232C6]^ Although several attempts of software-based hybrid imaging integrating invasive coronary angiography and SPECT have been made to better match the coronary arteries with the corresponding perfused myocardial territories, this was not widely implemented into clinical practice, as its invasiveness does not allow pre-interventional non-invasive decision making.^[@EHR232C6]--[@EHR232C9]^ With the introduction of coronary computed tomography angiography (CCTA), a non-invasive method for accurate visualization of coronary anatomy is now available.^[@EHR232C10]^ This has paved the way for purely non-invasive SPECT/CT hybrid imaging,^[@EHR232C11]^ directly relating individual myocardial perfusion territories to the subtending coronary artery. Although the integration of SPECT or PET devices with multislice CT scanners into hybrid devices has increased the interest in cardiac fusion imaging^[@EHR232C12],[@EHR232C13]^ and recent results confirm its diagnostic strengths,^[@EHR232C14],[@EHR232C15]^ the added clinical value of cardiac hybrid imaging in the decision making for treatment strategy selection has not yet been documented. The aim of the present study was to evaluate the impact of fused SPECT and CCTA cardiac imaging on the subsequent treatment strategy of CAD.

Methods {#s2}
=======

Patients {#s2a}
--------

We included 318 consecutive patients who were referred for the evaluation of known or suspected CAD by SPECT-MPI and CCTA within 1 ± 3 days. The results of the fused SPECT-MPI and CCTA images were reported to the referring physician who took into account the hybrid imaging test result, as well as the clinical history and the symptoms to make a decision towards invasive coronary angiography or conservative management. Patients were followed for revascularization procedures, including percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) after completing cardiac hybrid imaging. Follow-up was confined to the first 60 days after hybrid imaging as this allows best to assess the treatment strategy decisions including the revascularization procedure directly triggered by its findings, while later interventions are not directly triggered by the hybrid imaging results but rather reflect events of the natural course of the disease process. The study protocol was approved by the institutional review board (local ethics committee) and written informed consent was obtained from each patient before enrolment. The study population was in part shared with the recently reported registry on long-term outcome prediction by hybrid SPECT/CT imaging.^[@EHR232C16]^ The pre-test likelihood of CAD was determined using the Diamond and Forrester method, with a risk threshold of \<13.4% for low risk, between 13.4 and 87.2% for intermediate risk, and \>87.2% for high risk, as previously reported.^[@EHR232C17]^

Hybrid imaging {#s2b}
--------------

All patients underwent a 1-day stress/rest SPECT-MPI protocol with standard adenosine stress (0.14 mg/kg/min over 6 min)^[@EHR232C18]^ on a dual-head gamma camera (Millenium VG and Hawkeye or Ventri, both GE Healthcare, Milwaukee, Wisconsin) as previously reported.^[@EHR232C19]^ On a stand-alone 64-slice CT scanner (LightSpeed VCT, GE Healthcare), a low-dose CT was performed for attenuation correction of SPECT-MPI.^[@EHR232C20]^ In addition, all patients underwent contrast-enhanced CCTA with helical scanning (*n*= 248) or prospective ECG triggering (*n*= 70) as previously described in detail.^[@EHR232C21]--[@EHR232C23]^ In order to achieve a target heart rate \<65 bpm, intravenous metoprolol (5--20 mg) was administered prior to the CCTA examination if necessary. Patients with atrial fibrillation were not referred for CCTA. Furthermore, all patients received 2.5 mg sublingual isosorbiddinitrate 2 min prior to the scan.

Images from SPECT-MPI and CCTA were fused on a dedicated workstation (Advantage Workstation 4.3, GE Healthcare) using the CardIQ Fusion software package (GE Healthcare) as previously described in detail.^[@EHR232C24]^ Briefly, an optimized alignment tool allows projection of the SPECT image on the left ventricular epicardial surface obtained from the CCTA. The 3D volume rendered fusion images allow a panoramic view of the coronary artery tree projected onto the left ventricular myocardial perfusion territories. Then images can be displayed in freely selectable angles and displayed in standard anterior, posterior, lateral, and apical view for standardized documentation and reporting (*Figure [1](#EHR232F1){ref-type="fig"}*). Radiation dose for SPECT-MPI was calculated as ^99m^Tc-tetrofosmin activity times 7.9 mSv/GBq, while effective radiation dose for CCTA was estimated as dose-length product times a conversion coefficient for the chest *k* = 0.014 mSv/(mGy·cm). Figure 1Matched hybrid finding in single-photon emission computed tomography/computed tomography showing in the posterior (*A*) and anterior (*B*) view an ischaemia of the apex (arrowheads) in a territory subtended by a stenotic LAD (arrow) as further documented in the multiplanar coronary computed tomography angiography reconstruction (*C*).

Hybrid image interpretation {#s2c}
---------------------------

Two experienced nuclear cardiologists analysed the fused SPECT and CCTA images by consensus with regard to functionally relevant coronary stenoses. For each patient, myocardial tomograms were divided into 20 segments. Following 5-point system was used to score the segments: 0 = normal, 1 = equivocal, 2 = moderate, 3 = severe reduction of radioisotope uptake, 4 = absence of detectable tracer in a segment. An abnormal scan was defined as one in which two or more segments had stress scores ≥2. A scan was classified as reversible perfusion defect if a stress defect was associated with a rest score ≤1 or a stress defect score of 4 with a rest score of 2. As ischaemia-driven patient management is most evidence-based only reversible defects were considered for further analysis.

A matched SPECT/CT hybrid imaging finding was defined as a reversible SPECT-MPI defect in a territory subtended by a stenotic coronary artery (defined as narrowing of the coronary luminal diameter ≥50%). All other combinations of pathologic findings were classified as unmatched. Consequently, in order to assess the clinical value of hybrid images on decision making for treatment strategy selection, all patients were assigned to one of the following three categories of findings: (i) matched: CCTA and matched (reversible) SPECT findings as defined above; (ii) unmatched: any unmatched pathologic finding from CCTA and/or SPECT; (iii) normal: no pathologic finding, i.e. no stenosis by CCTA and no (fixed or reversible) defect by SPECT.

Statistical analysis {#s2d}
--------------------

SPSS software (SPSS 15.0, SPSS Inc.) was used for statistical testing. Quantitative variables were expressed as mean ± standard deviation and categorical variables as frequencies or percentages. The Chi-square test was used to compare the revascularization rates between the different patient groups. *P*-values from two-sided tests of less than 0.05 were considered statistically significant.

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

Coronary computed tomography angiography and SPECT were successfully performed in 318 patients. Baseline characteristics of the study population are given in *Table [1](#EHR232TB1){ref-type="table"}*. Table 1Baseline characteristics*n*318Age (years)61 ± 11Males, *n* (%)213 (67)Risk factors, *n* (%) Hypertension177 (56) Dyslipidaemia143 (45) Diabetes44 (14) Smoking92 (29) Positive family history87 (27)Reason referral, *n* (%) Pre-operative evaluation, equivocal/abnormal stress test122 (38) Non-anginal chest pain58 (18) Atypical angina60 (20) Typical angina46 (14) Dyspnoea32 (10)Pre-test likelihood of CAD, *n* (%) Low24 (10) Intermediate182 (73) High44 (17) Known CAD, *n* (%)68 (21) Previous MI19 (6)[^3]

Single-photon emission computed tomography and coronary computed tomography angiography findings {#s3b}
------------------------------------------------------------------------------------------------

Single-photon emission computed tomography revealed normal perfusion in 248 patients (78%) and an abnormal perfusion in 70 patients (22%). A normal CCTA examination was observed in 209 patients (66%), while CCTA identified a significant stenosis in 109 patients (34%). Matched pathologic hybrid findings (CCTA stenosis with corresponding reversible MPI defect) were observed in 51 patients (16%). Unmatched findings were present in 74 patients (23%), while the remaining patients were normal by both imaging methods (*n*= 193, 61%).

The effective radiation dose for stress/rest SPECT-MPI was 10.1 ± 0.9 mSv, while the estimated radiation dose for the CCTA was 17.9 ± 5.8 mSv when helical scanning was used (*n*= 248). After introducing prospective triggering for CCTA, the effective radiation dose was systematically recorded and resulted in 1.9 ± 0.5 mSv (*n*= 70).

Impact on patient management {#s3c}
----------------------------

During follow-up, of the patients with matched findings (*n*= 51) by hybrid cardiac imaging, 31 (61%) were further evaluated by invasive coronary angiography of whom 21 underwent a revascularization procedure (PCI: *n*= 20; CABG: *n*= 1), thus resulting in a revascularization rate of 41%. In 15 of the 20 patients not further evaluated by invasive angiography, the reason for not being referred to invasive angiography was the limited extent of the ischaemia, which was significantly smaller (2.7 ± 5.0%) than in those patients referred to angiography (9.0 ± 9.1%, *P*\< 0.001). In the remaining five patients, other reasons for conservative decision were observed such as for example difficult lesion accessibility.

In the patient group with unmatched findings (*n*= 74), 15 (20%) underwent invasive coronary angiography, of whom in 8 patients revascularization was performed (PCI: *n*= 6; CABG: *n*= 2). This resulted in a revascularization rate of 11% which was substantially lower than in the group with matched findings (i.e. 41%; *P*\< 0.001). In contrast, in the normal group, no invasive coronary angiography was performed (*Figure [2](#EHR232F2){ref-type="fig"}*). Figure 2The frequency of revascularization was significantly different among the three patient groups, i.e. that with normal, unmatched, and matched hybrid findings (*P*\< 0.001 by Chi-square test).

Of note, in the matched groups, the yield of CAD per angiography was 90% with a PCI rate per angiography of 68%, compared with 80% and 53% in the unmatched group.

Discussion {#s4}
==========

The present study shows that cardiac hybrid imaging with fused SPECT/CT images provides an added clinical value in the decision-making process leading to adequate treatment strategy.

Despite the fact that invasive coronary angiography is costly and associated with a small, but significant rate of procedural and in hospital morbidity and mortality,^[@EHR232C25],[@EHR232C26]^ so far, invasive coronary angiography has remained the gold standard for the detection of CAD and decision-making for or against a revascularization procedure. Nevertheless, it has been suggested that for best clinical practice, myocardial perfusion should also be assessed in addition to the anatomical information provided by angiography. Indeed, only under these conditions may an appropriate and evidence-based clinical decision-making process ensue. This has been recently confirmed by the prospective randomized FAME trial using coronary pressure measurements during angiography.^[@EHR232C2]^ Myocardial perfusion imaging with SPECT is a well-established non-invasive method for the assessment of myocardial ischaemia. A recently introduced non-invasive method for assessing coronary anatomy is CCTA. Although CCTA is accurate and helpful in risk stratification,^[@EHR232C10],[@EHR232C27]^ it has been recognized that CCTA alone may not replace conventional invasive CA as it essentially also only provides anatomical information. However, the latest advance in non-invasive cardiac imaging allows to obtain hybrid images from separately acquired CCTA and SPECT-MPI images.^[@EHR232C28]^ This has been shown to be helpful in clinical routine, as it allows non-invasive and comprehensive assessment of CAD based on anatomical and functional information and thus may contribute to avoid unnecessary invasive angiographies.^[@EHR232C5]^ A previous study documented that hybrid imaging may indeed provide added diagnostic information.^[@EHR232C28]^ However, that study evaluated patients already selected for invasive coronary angiography. Thus, it remained unclear whether and how the findings obtained by hybrid imaging may have impacted on the clinical decision process. Moreover, that study used fixed and reversible defects on hybrid images to assess the clinical value of hybrid imaging. In contrast, the current study used only reversible defects because ischaemia in territories subtended by stenotic coronaries constitutes the primary indication for revascularization, while scar tissue does not. This may have contributed to the fact that hybrid findings had a major impact on clinical decision making in patients evaluated for CAD. The substantial difference in intervention frequencies between matched and unmatched findings reflects the difficulty in determining the appropriate therapy for patients with chronic stable CAD as, for example, seen in the COURAGE trial.^[@EHR232C29]^ This is further evidenced by the fact that even in the group with matched findings, not all lesions were revascularized as optimal medical treatment offers an excellent alternative in many patients. Hybrid imaging provides a solid ground on which decision making towards revascularization can be based. The correct identification of patients who qualify for invasive coronary angiography and potentially for intervention by hybrid imaging may help saving the cost and the risk of unnecessary diagnostic angiography and ineffective revascularization. In fact, the yield of CAD by invasive angiography after initial evaluation by hybrid imaging was 90%, comparing favourably with the low yield of 39% recently reported in a large registry of elective diagnostic angiographies.^[@EHR232C30]^ Consequently, the improved non-invasive evaluation by hybrid imaging increased the intervention rate per diagnostic angiography to 68% in the group with matched findings, a proportion which is substantially higher than figures reported in registries of most European countries. For example, in the German registry, a PCI or a bypass was only performed in 36% of the patients undergoing an elective invasive angiography.^[@EHR232C31]^

We acknowledge the following limitations to our study: Although patients were included consecutively, there was no randomization to different treatment strategies as in this prospective observational study the impact of cardiac hybrid imaging on clinical decision-making in daily clinical routine was assessed. Further prospective clinical studies are necessary to define whether this hybrid SPECT/CT-guided approach has a positive effect on long-term outcome. In parallel, this would offer an assessment of cost efficacy. From the present data, we cannot prove that without non-invasive imaging, all patients would have been referred for invasive angiography. Nevertheless, the fact that 90% of the present study population represent an intermediate to high-risk population seems to support the notion that in 80% of the patients of the present study with unmatched findings an invasive angiography was avoided, although no data on the clinical benefit were obtained. Finally, the additive radiation burden from combined nuclear and CT scanning is a limitation of this approach as values of up to 41 mSv have been initially reported.^[@EHR232C32]^ However, the mean radiation dose in the first 248 patients was substantially lower, namely 28 mSv. Furthermore, radiation dose can be reduced significantly by implementing dose reduction techniques for SPECT^[@EHR232C33]--[@EHR232C35]^ and by using prospective ECG-triggering for CCTA.^[@EHR232C22],[@EHR232C23],[@EHR232C36]^ Of note, the latter has been used for the last 70 patients in the present study, resulting in an effective radiation dose of 1.9 ± 0.5 mSv for CCTA reducing the cumulative effective dose of the entire SPECT/CT study to 12 mSv. Combining optimized SPECT and CT will allow to reach values below 5 mSv^[@EHR232C34]^ and in optimal cases below 3 mSv for such hybrid examinations.^[@EHR232C37]^

Thus, in summary, cardiac hybrid imaging with SPECT and CCTA is a feasible tool providing an added clinical value for decision making with regard to treatment strategy for CAD.
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